Survival of castration‐resistant prostate cancer patients treated with dendritic–tumor cell hybridomas is negatively correlated with changes in peripheral blood CD56 bright CD16 − natural killer cells-Reference-Cited by-同舟云学术

Survival of castration‐resistant prostate cancer patients treated with dendritic–tumor cell hybridomas is negatively correlated with changes in peripheral blood CD56 bright CD16 − natural killer cells

Published:2021-08 Issue:8 Volume:11 Page:
ISSN:2001-1326
Container-title:Clinical and Translational Medicine
language:en
Short-container-title:Clinical and Translational Medicine

Author:

Haque Chowdhury Helena¹²^ORCID,Hawlina Simon³⁴,Gabrijel Mateja¹²,Trkov Bobnar Saša¹²,Kreft Marko¹²⁵,Lenart Gordan³,Cukjati Marko⁶,Kopitar Andreja Nataša⁷,Kejžar Nataša⁸,Ihan Alojz⁷,Ležaič Luka⁹¹⁰,Grmek Marko⁹,Kmetec Andrej³,Jeras Matjaž¹¹¹,Zorec Robert¹²^ORCID

Affiliation:

1. Laboratory of Cell Engineering Celica Biomedical Ljubljana Slovenia

2. Laboratory of Neuroendocrinology – Molecular Cell Physiology, Institute of Pathophysiology, Faculty of Medicine University of Ljubljana Ljubljana Slovenia

3. Clinical Department of Urology University Medical Centre Ljubljana Ljubljana Slovenia

4. Department of Surgery, Faculty of Medicine University of Ljubljana Ljubljana Slovenia

5. CPAE, Department of Biology, Biotechnical Faculty University of Ljubljana Ljubljana Slovenia

6. Blood Transfusion Centre of Slovenia Ljubljana Slovenia

7. Institute of Microbiology and Immunology, Faculty of Medicine University of Ljubljana Ljubljana Slovenia

8. Institute for Biostatistics and Medical Informatics, Faculty of Medicine University of Ljubljana Ljubljana Slovenia

9. Department of Nuclear Medicine University Medical Centre Ljubljana Ljubljana Slovenia

10. Department of Radiology, Faculty of Medicine University of Ljubljana Ljubljana Slovenia

11. Faculty of Pharmacy University of Ljubljana Ljubljana Slovenia

Funder

European Cooperation in Science and Technology

Publisher

Wiley

Subject

Molecular Medicine,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ctm2.505

Reference10 articles.

1. Peripheral Blood NK Cells from Breast Cancer Patients Are Tumor-Induced Composite Subsets

2. Expansion of CD16-Negative Natural Killer Cells in the Peripheral Blood of Patients with Metastatic Melanoma

3. Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer

4. Dendritic-Tumor Fusion Cell-Based Cancer Vaccines

5. Blood‐derived dendritic cell vaccinations induce immune responses that correlate with clinical outcome in patients with chemo‐naive castration‐resistant prostate cancer;Westdorp H;J Immunother Cancer,2019

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Natural killer cell activity in metastatic castration resistant prostate cancer patients treated with enzalutamide;Scientific Reports;2023-10-10

2. Potential of Personalized Dendritic Cell-Based Immunohybridoma Vaccines to Treat Prostate Cancer;Life;2023-07-01

3. Integrative Analysis of Bulk RNA-Seq and Single-Cell RNA-Seq Unveils the Characteristics of the Immune Microenvironment and Prognosis Signature in Prostate Cancer;Journal of Oncology;2022-07-19

4. Dendritic cell-based vaccine prolongs survival and time to next therapy independently of the vaccine cell number;Biology Direct;2022-02-23